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Endovascular repair of infrarenal aortic aneurysms
in octogenarians and nonagenarians
Philipp Geisbüsch, MD,a,c Barry T. Katzen, MD,a Athanassios I. Tsoukas, MD,b Dillon Arango,a
Constantino S. Peña, MD,a and James F. Benenati, MDa Miami, Fla; and Heidelberg, Germany
Objective: The purpose of this report was to present short and midterm results of endovascular aortic aneurysm repair
(EVAR) of infrarenal aortic aneurysms in octogenarians and nonagenarians.
Methods: Between March 1994 and March 2011, elective EVAR was performed in 967 patients in our institution. This
includes 279 patients older than 80 years at the time of the procedure (octogenarians: n 252, nonagenarians: n  27).
Mean follow-up was 48.4  34.5 months. A retrospective analysis was performed. Survival was calculated using
Kaplan-Meier analysis and a survival comparison to patients who underwent EVAR <80 years old (n  688) was
performed. Cox hazard regression analysis was used to assess parameters that influence survival.
Results: Technical success was 96% in octogenarians and 85% in nonagenarians. Technical failure in 15 of 279 patients
includes primary type I endoleak (n  6), procedure abortion due to inability to pass the iliac vessels (n  6), and
emergency conversion (n  3). Thirty-day mortality was significantly higher for patients >80 years old (2.8% vs 1.0%;
P  .044). Morbidity rates were 11.5% for octogenarians and 7.4% for nonagenarians with predominately cardiopulmo-
nary complications. High-risk patients>80 years old showed a comparable perioperative mortality rate to low-/medium-
risk patients >80 years old (2.9% vs 2.5%;P  .717), but a significantly higher complication rate (22.5% vs 9.2%; P 
.0275) and reduced midterm survival with 1-, 3-, and 5-year survival rates of 79% SE 7%, 55% SE 8%, and 38% SE
9% (log-rank test P .03). In high-risk patients age>80 years old, their age did not influence 30-day mortality (2.5% vs
2.7%; P .978) and midterm survival. Survival in octogenarians at 1, 3, and 5 years was 87.9 SE 2.1%, 70.9 SE 3.0%,
and 55.6% SE 3.5%, respectively. Survival in nonagenarians at 1 and 3 years was 96.3% SE 4% and 60.6% SE 10.4%.
Higher cardiac (hazard ratio [HR], 1.22; P  .038) and renal risk scores (HR, 1.59; P  .0016), chronic obstructive
pulmonary disease (HR, 1.56; P  .032), and anemia (HR, 2.1; P < .001) influenced midterm survival.
Conclusion: EVAR in octogenarians and nonagenarians is associated with a significantly higher but still low perioperative
mortality compared to younger patients. Midterm survival in octogenarians and nonagenarians, although significantly
lower than in younger patients, is still acceptable, indicating that age >80 years should not be an exclusion criteria for
EVAR. Even high-risk patients >80 years can be treated safely with a low perioperative mortality and comparable
midterm outcome to younger high-risk patients. ( J Vasc Surg 2011;54:1605-13.)
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pThe elderly are one of the fastest growing population
segments in many industrial countries. For the United
States, the number of people aged 85 years in 2050 is
estimated at 21 million, an increase from 1.5% to 5% of the
total population.1 Similar findings are reported for the
European Union, where the number of people aged 80
years is projected to almost triple from 21.8million in 2008
to 61.4 million in 2060.2 As the occurrence of abdominal
aortic aneurysms (AAAs) is age related, there will be a
growing number of patients older than 80 years seeking
treatment for an AAA in the future.3,4 At present, endovas-
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doi:10.1016/j.jvs.2011.06.096ular aortic aneurysm repair (EVAR) is the first-line treat-
ent option for patients with infrarenal aortic aneurysms in
any centers. Although excellent results for open surgery
n octogenarians have been reported, EVAR seems espe-
ially appealing in elderly patients, generally considered at
igh risk for open surgical aneurysm repair.5 Although
VAR is certainly technically feasible in octogenarians/
onagenarians, questions remain regarding the indication
or treatment while balancing the natural course of the
isease and life expectancy against the short-term (mortal-
ty, morbidity) and midterm (eg, reintervention rate, cost-
ffectiveness) complications of EVAR. The purpose of this
tudy was, therefore, to report and analyze our short- and
id- to long-term results of EVAR in octogenarians and
onagenarians in a large, continuous patient cohort. We
urther aimed to identify possible risk factors that might
elp to improve patient selection in this subgroup of pa-
ients.
ETHODS
Patient population. BetweenMarch 1994 andMarch
011, EVAR of an infrarenal aortic aneurysm was per-
ormed in 958 patients in our institution. This includes 279
atients older than 80 years at the time of the procedure
octogenarians: n  252, nonagenarians: n  27), which
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December 20111606 Geisbüsch et alrepresent the study population (Table I). Patients with
ruptured aortic aneurysms, reinterventions after previous
EVAR, and patients requiring fenestrated stent grafts were
excluded from this analysis. Generally, in consensus with
the practice guidelines, the minimum threshold for elective
EVAR procedures was a maximum aneurysm diameter of
5.5 cm, but even in AAAs 5.5 cm, treatment decision
was individually based considering comorbidities and the
patients’ will.6 Median aneurysm diameter for octogenari-
ans was 60 mm (range, 5.5-9 cm), 71 mm for nonagenar-
ians (range, 5.5-10 cm), and 6.4 cm (range, 5.5-11 cm) for
Table I. Demographics, risk factors, and comorbidities of
(n  279)
Total (n 
Age (years) 84.6  3
Gender (male) 238 (8
BMI (kg/m2) 26.1  3
Baseline hemoglobin (g/dL) 13.1  1
Baseline hematocrit (%) 39.1  5
Anemia 116 (4
Baseline creatinine clearancea (mL/min) 42.4  1
Stage of chronic kidney disease
1 (GFRa 130-90 mL/min) —
2 (GFRa 90-60 mL/min) 35
3 (GFRa 60-30 mL/min) 187
4 (GFRa 30-15 mL/min) 49
5 (GFRa 15 mL/min) 7
Diabetes mellitus 36 (1
Hyperlipidemia 147 (5
Hypertension 246 (8
COPD 90 (3
History of smoking 200 (7
History of cerebrovascular disease 54 (1
History of PAOD 101 (3
CAD 106 (3
ASA score
I —
II 2 (1
III 221 (7
IV 56 (2
SVS-AAVS medical comorbidity grading system
Cardiac risk level
0 62 (2
1 34 (1
2 165 (5
3 18 (6
Renal risk level
0 203 (7
1 64 (2
2 9 (3
3 3 (1
Pulmonary risk level
0 134 (4
1 83 (3
2 42 (1
3 20 (7
ASA, American Society of Anesthesiologists; BMI, body mass index; CAD,
endovascular aortic aneurysm repair; GFR, glomerular filtration rate; P
Surgery/American Association for Vascular Surgery.
Values are given as n (%) or mean  SD.
aCalculated by Cockcroft-Gault-Formula.high-risk patients/American Society of Anesthesiology cASA) class IV patients. For preoperative risk stratification,
he patients were scored using the ASA classification and
he medical comorbidity grading system suggested by the
d Hoc Committee for Standardized Reporting Practices
n Vascular Surgery of the Society for Vascular Surgery/
merican Association for Vascular Surgery.7 This medical
omorbidity grading system is a score that involves age,
ardiac, pulmonary, and renal-related risk factors (level
/1  low/minimal risk to level 2/3  moderate/high-
isk level). Demographics, risk factors, and comorbidities of
he patients are given in Table I. A total of 40 patients were
atients older than 80 years undergoing elective EVAR
Octogenarians (n  252) Nonagenarians (n  27)
83.9  2.6 91.6  1.5
213 (84) 25 (93)
26.1  3.7 25.5  3.2
13.1  1.7 12.5  1.4
39.2  5.2 37.8  4.0
100 (40) 16 (59)
43.2  14.8 34.9  11.2
— —
34 1
172 15
38 11
7 —
34 (13) 2 (7)
135 (54) 12 (44)
221 (88) 25 (93)
84 (33) 6 (22)
183 (73) 17 (63)
50 (20) 4 (15)
91 (38) 10 (37)
96 (38) 10 (37)
— —
2 (1) —
206 (82) 15 (55)
44 (17) 12 (45)
60 (24) 2 (7)
33 (13) 1 (4)
142 (56) 23 (85)
17 (7) 1 (4)
184 (73) 19 (70)
56 (22) 8 (30)
9 (3) —
3 (1) —
118 (47) 15 (59)
76 (30) 6 (22)
39 (15) 3 (11)
18 (7) 2 (7)
ary artery disease; COPD, chronic obstructive pulmonary disease; EVAR,
, peripheral arterial occlusive disease; SVS-AAVS, Society for Vascularall p
279)
.4
5)
.7
.7
.1
2)
4.9
3)
3)
8)
2)
2)
9)
6)
8)
)
9)
0)
2)
2)
9)
)
3)
3)
)
)
8)
0)
5)
)
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Volume 54, Number 6 Geisbüsch et al 1607nal, and pulmonary risk levels (6%, 0.7%, and 7%, respec-
tively). A survival comparison to all patients80 years (n
688) that underwent EVAR during the same time period in
our institution was performed. This younger patient cohort
included a comparable proportion of high-risk patients
(14% vs 11%; P  .222).
Procedure. All procedures were performed with an
interdisciplinary team involving vascular surgeons, inter-
ventional radiologists, and anesthesiologists in an angiog-
raphy suite. Procedural details are given in Table II. The
following stent grafts were used: Talent (Medtronic, Santa
Rosa, Calif; n  81), Excluder (W. L. Gore & Associates,
Flagstaff, Ariz; n  77), AneuRx (Medtronic; n  36),
Zenith (Cook, Bloomington, Ill; n  43), Ancure
(Guidant, Menlo Park, Calif; n  35), Vanguard (Boston
Scientific, Natick, Mass; n  4), and Trivascular (Boston
Scientific; n  3). The majority of patients were treated
under locoregional/regional anesthesia (91%) with a surgi-
Table II. Procedure-specific data
Total (n  279)
Type of anesthesia
Local 94 (34)
Regional 159 (57)
General 26 (9)
Type of arterial access
Cut down/cut down 202 (72)
Cut down/percutaneous 66 (24)
Percutaneous/percutaneous 11 (4)
Operating time (minutes) 158  69
Fluoroscopic time (minutes) 28  13
Contrast volume (mL) 165  74
Table III. Thirty-day outcome of 279 patients older than
infrarenal aortic aneurysm
Total (n  279)
Thirty-day mortality 8 (2.8)
Perioperative morbidity 29 (10.3)
Cardiac complications 9 (3.2)
Respiratory complications 4 (1.4)
Renal complications 8 (2.8)
Access site complications 7 (2.5)
Pancreatitis 1 (0.4)
MOF 1 (0.4)
Stroke 2 (0.7)
DVT 1 (0.4)
Peripheral embolization 1 (0.4)
Surgical conversion 3 (1.1)
Aborted procedure 6 (2.1)
Limb occlusion 2 (0.7)
Endoleak
Type I 6 (2)
Type II 40 (14)
Type III —
Type IV 29 (10)
ICU stay n (%) 23 (8)
Hospital stay (days) 3 (1-106)
DVT, Deep vein thrombosis; ICU, intensive care unit; MOF, multiorgan fa
Values are given as n (%) or median (range).cal cut down (72%). dFollow-up. Patients were routinely followed by our
nstitution and follow-up included postoperative computed
omographic angiography (CTA) before discharge/30
ays, and CTA/magnetic resonance angiography 6 and 12
onths postoperatively and annually thereafter. Mean
ollow-up was 48.4  34.5 months for the total study
opulation, 49.7  35.3 months for octogenarians, and
6.1 22.2months for nonagenarians. The Social Security
eath Index (http://ssdi.rootsweb.com) was used to as-
ertain mortality as of March 1, 2011.
Definitions and statistical analysis. Technical suc-
ess and endoleaks were defined according to the reporting
tandards for EVAR.8 Anemia was defined according to the
orld Health Organization definition as a hemoglobin
evel 13 g/dL in men and 12 g/dL in women.9 Pul-
onary complications were defined as pneumonia, re-
uired pharmacologic or ventilator support, and worsening
f pre-existing pulmonary impairment. Renal failure was
ctogenarians (n  252) Nonagenarians (n  27)
81 (32) 13 (48)
148 (59) 11 (41)
23 (9) 3 (11)
180 (71) 22 (81)
63 (25) 3 (11)
9 (4) 2 (8)
158  71 158  61
28  13 31  15
164  75 170  73
ears undergoing elective endovascular repair of an
ogenarians (n  252) Nonagenarians (n  27)
8 (3.2) 0
27 (10.7) 2 (7.4)
9 (3.5) 0
4 (1.6) 0
8 (3.2) 0
5 (2) 2 (7.4)
1 (0.4) 0
1 (0.4) 0
2 (0.7) 0
1 (0.4) 0
0 1 (3.7)
2 (0.7) 1 (3.7)
4 (1.6) 2 (7.4)
2 (0.7) 0
5 (2) 1 (3.7)
38 (15) 2 (7.4)
— —
26 (10) 3 (11)
19 (7.5) 4 (15)
3 (1-106) 3 (2-13)O80 y
Octefined as required temporary or permanent dialysis. Ret-
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December 20111608 Geisbüsch et alrospective analysis of the data was performed. Institutional
review board approval for retrospective review of the study
patients was obtained. Data are expressed as mean SD or
median (range). Survival estimates were generated using
the Kaplan-Meier analysis and the log-rank test was used for
survival comparisons. The 2 test was used for the compar-
ison of categorical variables. Cox hazard regression analysis
was used to assess parameters that influence survival. All
statistical analysis was performed using MedCalc (version
9.5.2, MedCalc Software, Mariakerke, Belgium). A P value
 .05 was defined statistically significant.
RESULTS
Technical success in the total study population was
achieved in 264 of 279 patients (94.6%) and was 96% (241
of 252 patients) in octogenarians and 85% (23 of 27
patients) in nonagenarians. Technical failure in 15 of 279
patients includes six patients with a primary type I en-
doleak, six patients with an aborted procedure due to
inability to pass the iliac vessels with the endograft, and
three patients with emergency conversion (described be-
low). All patients with type I endoleaks were detected on
the postoperative CTA and the patients received successful
reinterventions (Palmaz stent; Cordis Endovascular, War-
Fig 1. Kaplan-Meier survival analysis of octogenarian
endovascular aortic aneurysm repair (EVAR) in our instiren, NJ; n  2; proximal extension cuff, n  4). pMortality and morbidity. The 30-day mortality was
.8% for the total study population with all eight deaths
ccurring in octogenarians (3.2%). Cause of death was
yocardial infarction (n  3), pneumonia (n  1), multi-
rgan failure after emergency conversion (n  1), and
ancreatitis with cardiac arrest (n  1). An additional two
atients died after an initial uneventful course (no compli-
ation, no endoleak) on the 26th and 27th postoperative
ay after discharge. The cause of death was stroke in one
atient and remained unknown in the other patient. Peri-
perative complications occurred in 31 of 279 patients
11%). Themorbidity rate was 11.5% for octogenarians and
.4% for nonagenarians (Table III). Cardiac complications
ere seen in nine patients (3 myocardial infarction, 1
ongestive heart failure, and 5 arrhythmia). Pulmonary
omplications (n  4) included pneumonia (n  2) and
espiratory failure (n  2) due to worsening of a pre-
xisting chronic obstructive pulmonary disease (COPD). A
otal of eight patients required temporary (n  3) or
ermanent dialysis (n  5). Access site complications in-
luded rupture of the access vessel (n  2), groin hema-
oma requiring transfusion/surgical revision (n  2), and
roin infection causing intravenous antibiotic therapy and
urgical revision (n  2). Limb occlusions occurred in two
 252) and nonagenarians (n  27) that received
.s (natients (0.7%) on postoperative day 9 and 30 and were
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Volume 54, Number 6 Geisbüsch et al 1609successfully treated with thrombectomy and stent graft
placement.
Transfusion of red blood cells was necessary in 48
patients (17%). Emergency conversion was performed in
three patients (1%). This includes two patients with intra-
operative aortic/iliac rupture (both patients survived 4,
respectively, 6.5 years postoperative) and one patient with
Fig 2. Kaplan-Meier survival analysis shows a significan
279) compared to younger patients undergoing elective e
.0001).
Table IV. Comparison of 30-day mortality and midterm
survival of patients 80 years (n  279) and patients
80 years (n  688) that underwent elective EVAR
Parameter
Patients 80
years
(n  279)
Patients 80
years
(n  688) P value
Thirty-day mortality 2.8% 1.0% .044
Midterm survivala
1 year 87%  SE 2% 91%  SE 1%
2 years 79%  SE 2% 87%  SE 1% .0001a
3 years 70%  SE 3% 81%  SE 2%
5 years 52%  SE 3% 70%  SE 2%
EVAR, Endovascular aortic aneurysm repair.
aKaplan-Meier survival analysis (log-rank test).bilateral accidental coverage of the renal artery that could (ot be resolved by endovascular bailout techniques (patient
ied due to multiorgan failure on the second postoperative
ay). All these cases showed challenging aneurysm mor-
hologies with respect to small access vessels (n  1) and
hort/angulated neck (n  2).
Midterm results. Secondary endoleaks were observed
n 10 patients (3.6%). This includes six patients with type I
ndoleaks, three patients with type II endoleaks, and one
atient with endotension. Reintervention was necessary in
0 of 279 patients (10.7%) with no significant difference
etween octogenarians (10.7%) and nonagenarians (11%).
auses for reintervention were primary (n  6) or second-
ry (n  6) type I endoleaks, type II endoleaks (n  13),
ndotension (n 1), graft limb occlusions (n  2), caudal
raft migration (n 1), and renal artery impairment by the
ndograft (n  1). Kaplan-Meier analysis of survival in
ctogenarians showed 1-, 3-, and 5-year survival rates of
7.9  SE 2.1%, 70.9  SE 3.0%, and 55.6%  SE 3.5%,
espectively. Survival in nonagenarians at 1, 3, and 5 years
as 96.3%  SE 4%, 60.6%  SE 10.4%, and 15%  SE
.5% (Fig 1). During follow-up, 166 patients died (59%).
n three of 279 patients (1.1%), death was related to the
neurysm, in 66 of 166 patients (40%), it was attributed to
he comorbidities of the patient, and in 97 of 166 patients
duced midterm survival for patients 80 years old (n 
ascular aortic aneurysm repair (EVAR; log-rank test Ptly re
ndov58%), the actual cause of death remained unknown. In
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December 20111610 Geisbüsch et althese 97 patients, the median time interval between death
and last imaging follow-up was 23 months (range, 1-106
months).
The group of octogenarians/nonagenarians (n 279)
was compared to all patients 80 years old (n  688) that
underwent EVAR during the same time period in our
institution. Patients 80 years old showed a significantly
higher 30-day mortality rate (2.8% vs 1.0%; P  .044) and
significantly lower survival rate than the younger cohort
Fig 3. Kaplan-Meier survival analysis shows a significan
old (n  40) compared to low-/medium-risk patients 
Table V. Comparison of 30-day mortality and midterm
survival of high-risk (n  40) and low-/medium-risk (n
 239) patients 80 years old undergoing elective
endovascular repair of an infrarenal aortic aneurysm
Parameter
High-risk
patients 80
years
(n  40)
Low-/moderate-
risk patients
80 years
(n  239)
P
value
Thirty-day mortality 2.5% 2.9% .717
Midterm survivala
1 year 79%  SE 7% 90%  SE 2%
2 years 70%  SE 8% 81%  SE 3% .0399a
3 years 55%  SE 8% 72%  SE 3%
5 years 38%  SE 9% 53%  SE 4%
aKaplan-Meier survival analysis (log-rank test).during follow-up (Table IV; Fig 2). sHigh-risk patients. The mortality rate for high-risk
ctogenarian/nonagenarian patients (n  40) was 2.5%
ith no statistical significant difference (P  .717) to
ow-/moderate-risk octogenarian/nonagenarian patients
2.9%). However, high-risk patients showed a significantly
igher complication rate (22.5% vs 9.2%; P  .0275) and
ad a significantly reduced midterm survival (Table V; Fig
). For patients classified as ASA IV, no significant differ-
nce in mortality (3.5% vs 2.6%; P  .9246) or morbidity
19% vs 13%; P  .895) was observed. A comparison of
igh-risk patients 80 years old with high-risk patients
80 years old showed no significant difference in 30-day
ortality (2.5% vs 2.7%; P  .978) or midterm survival
Table VI; Fig 4).
Cox hazard regression analysis, including cardiac, pul-
onary, and renal risk levels showed anemia (hazard ratio
HR], 2.1; P  .001) as the strongest influence factor on
urvival (Table VII).
ISCUSSION
The present series shows that endovascular repair of
nfrarenal aortic aneurysms in octogenarians and nonage-
arians is associated with a significantly higher, but still low
erioperative mortality compared to younger patients
2.8% vs 1%; P  .044). High-risk patients 80 years old
uced midterm survival for high-risk patients 80 years
ars old (log-rank test P  .0399).tly redhowed comparable perioperative mortality (2.5%), but a
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Volume 54, Number 6 Geisbüsch et al 1611significantly higher complication rate and significantly re-
duced midterm survival than low-/medium-risk patients
80 years old. Age did not influence the outcome in
high-risk patients. High-risk patients older and younger
than 80 years old showed a comparable perioperative mor-
tality and midterm survival. Reported mortality rates for
octogenarians after EVAR in larger series vary between 1%
and 5% and are thus in line with our results (3.2%).10-14
Fig 4. Kaplan-Meier survival analysis shows no significa
years old (n  40) compared to high-risk patients 80 y
Table VI. Comparison of 30-day mortality and midterm
survival of high-risk patients 80 years old (n  40) and
80 years old (n  74) undergoing elective endovascular
repair of an infrarenal aortic aneurysm
Parameter
High-risk
patients 80
years
High-risk
patients 80
years
P
value
Patients 40/279 (14%) 74/688 (11%) .222
Thirty-day mortality 2.5% 2.7% .978
Midterm survivala
1 year 78%  SE7% 83%  SE4%
2 years 70%  SE8% 68%  SE6% .428a
3 years 54%  SE8% 53%  SE6%
5 years 39%  SE9% 42%  SE6%
aKaplan-Meier survival analysis (log-rank test).Consistent with our findings, these series describe cardio- rulmonary complications as the predominant cause of peri-
perative death, which underlines the necessity for a
igorous preoperative cardiopulmonary evaluation and op-
imization of the patients. Cardiac (3.2%) and renal (2.8%)
omplications in our series are both within the reported
fference in midterm survival for high-risk patients 80
old (log-rank test P  .428).
able VII. Multivariable Cox regression analysis for
rediction of mortality during long-term follow-up of
79 consecutive patients older than 80 years undergoing
lective endovascular abdominal aortic aneurysm repair
ariable
Adjusteda
HR 95% CI P value
ardiac risk score 1.22 1.01-1.47 .038
ulmonary risk score 1.09 0.89-1.32 .371
enal risk score 1.59 1.19-2.13 .0016
nemia 2.12 1.51-2.99 .00001
ge (per year) 1.05 1.00-1.10 .041
OPD 1.56 1.03-2.35 .032
I, Confidence interval; COPD, chronic obstructive pulmonary disease;
R, hazard ratio.
Adjusted for age, gender, anemia, cardiac, pulmonary, and renal risk score,
istory of cancer, hyperlipidemia, diabetes mellitus, smoking, COPD, cere-
rovascular disease, coronary artery disease, hypertension, statin use, and
ype of anesthesia (general anesthesia).nt diange of the literature (1.7% to 7.5% for cardiac complica-
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December 20111612 Geisbüsch et altions and 3.5% to 6% for renal complications).11,12 How-
ever, we observed a lower rate of pulmonary complications
(1.8%) than reported in the European Collaborators on
Stent/Graft Techniques for Aortic Aneurysm Repair (EU-
ROSTAR) analysis (4.5%) and the series by Fonseca et al11
(5.1%). Two factors might have contributed to this result.
First, both series report a higher rate of patients with
pre-existing COPD/impaired pulmonary function, and
second, the vast majority of patients in these series were
treated under general anesthesia (70% in the EUROSTAR
data). In our series, general anesthesia was only used in 10%
of the patients and, given our findings, we would recom-
mend the use of local anesthesia in these patients. This large
single-center study of octogenarians and nonagenarians
with a mean follow-up of 48.4 months allows midterm
survival analysis, which indicates an acceptable midterm
survival in both patient cohorts. Octogenarians showed a
5-year survival rate of 55% which is comparable to the
EUROSTAR data (n  697 octogenarians, mean follow-
up 14 months) that showed a 64% survival at 5 years.12
Recently, Fonseca et al11 published their excellent results of
a cohort of 117 octogenarians and showed a 5-year survival
rate of 91.6%, which may represent a selection bias toward
a very robust octogenarian patient cohort as stated by the
authors. Recently, the US Census Bureau reported a life
expectancy of 5.7 years at the age of 85 years. In our cohort
(median age, 85 years), the median survival for patients
80 years was 5.2 years (range, 0-11.6 years).15 All these
data indicate that these patients might have a sufficient life
expectancy to benefit from the prophylactic nature of elec-
tive AAA repair. Perioperative results and survival data of
selected large series of nonagenarians, including ours, are
summarized in Table VIII.16-18 Technical success was only
achieved in 23 of 27 nonagenarians (85%), which might
reflect “pushing the envelope” to avoid open repair in these
patients, because technical failure included abortion of the
Table VIII. Selected studies reporting outcome of
EVAR in nonagenarians
Study Patients
Thirty-day
mortality Survival data
Goldstein et al16 24 4.2% 1-year survival: 83%
2-year survival: 64%
3-year survival: 50%
Prenner et al18 24 8.3% 1-year survival:
83.3%
5-year survival:
19.3%
Jim et al17 18 5.6% Mortality at 1 year:
41.2%
Mortality at 2 years:
58.3%
Miami experience 27 0% 1-year survival:
96.3%
3-year survival:
60.6%
EVAR, Endovascular aortic aneurysm repair.procedure for iliac rupture (n  1) or inability to pass the levice through the iliac artery, aortic rupture (n  1) after
tent graft deployment (conversion), and a type I (n  1)
ndoleak (successful reintervention).
A subgroup of patients that warrant attention are high-
isk patients 80 years old, because indication for treat-
ent is especially controversial in these patients. Our data
uggest that even high-risk patients 80 years can be
reated with low perioperative mortality (2.5%). High-risk
atients 80 years had a significantly higher complication
ate (n  9 of 40; 22.5%), but four of nine patients had
onsystemic (access, limb obstruction, bleeding) complica-
ions. High-risk patients showed a significantly reduced
idterm survival. However, 3- and 5-year survival rates of
4% SE 8% and 39% SE 9% and amedian survival of 3.5
ears (range, 0-10.8 years) might indicate that even high-
isk patients should not generally be excluded from EVAR
nd that further risk stratification tools for this subgroup
re needed. One aim of this study was to identify risk factors
hat influence survival in this patient cohort and thus help
o improve future patient selection. Besides a higher cardiac
nd renal risk score, the presence of COPD (HR, 1.56; P
032) and anemia (HR, 2.12; P .001) influenced survival.
n this series, anemia was present in 42% of the patients and
reoperative or postoperative transfusion of red blood cells
as necessary in a high proportion of patients (17%), a
nding confirmed by other series.11 We have previously
roven anemia to be associated with aneurysm size and
ecreased long-term survival after EVAR, and this series
lso suggests the role for anemia as a risk stratification tool
n elderly patients with AAA.19,20 Given the demographical
evelopment in most industrial countries, there is no doubt
hat more and more elderly patients with AAAs will seek
reatment in the future. The decision to treat these patients,
specially nonagenarians, remains at this point very individ-
al and controversial. It is dependent on patient comor-
idities, aneurysm size, and, importantly, the patients’ and
amilies’ desires. The mean diameter of the aneurysms that
ere treated in this series was 70 mm for nonagenarians.
alancing the risk of aneurysm rupture against the life
xpectancy of these patients, a higher than 5.5 cm aneu-
ysm diameter might be adequate as a threshold for treat-
ent in this subgroup of patients, especially in high-risk
atients with the aforementioned comorbidities. This study
oes not have a conservative control group of patients80
ears old with AAAs and ideally similar comorbidities and,
hus cannot define an AAA diameter threshold at which
ctogenarians or nonagenarians benefit from EVAR. At
resent, we tend to exclude patients that combine high
edical and high anatomic risk factors from EVAR, which
ight change in the future with improving endograft tech-
ology.
ONCLUSIONS
EVAR in octogenarians and nonagenarians is associ-
ted with a significantly higher, but still low perioperative
ortality compared to younger patients. Midterm survival
n octogenarians and nonagenarians, although significantly
ower than in younger patients, is still good, indicating that
11
1
1
1
1
1
1
1
1
2
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Volume 54, Number 6 Geisbüsch et al 1613age 80 years should not be an exclusion criteria for
EVAR. Even high-risk patients 80 years old can be
treated safely with a low perioperative mortality and accept-
able midterm outcome, which are comparable to younger
high-risk patients. Higher cardiac and renal risk scores,
COPD, and anemia influence survival and should be incor-
porated in specific risk stratification tools for this growing
subgroup of patients with AAAs.
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